Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants

  • Katherine E. Zarn
  • , Sierra A. Jaramillo
  • , Anthony R. Zapata
  • , Nathan E. Stone
  • , Ashley N. Jones
  • , Haley E. Nunnally
  • , Erik W. Settles
  • , Ken Ng
  • , Paul S. Keim
  • , Steen Knudsen
  • , Patricia M. Nuijten
  • , Aloys S.L. Tijsma
  • , Christopher T. French

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science